ImmunityBio Holds Golden Cross As Stock Trades 170% Above 200-Day Average

ImmunityBio Inc (NASDAQ:IBRX) stock is maintaining a confirmed Golden Cross, with the stock now trading roughly 170% above its 200-day moving average — a measurable signal of sustained long-term trend strength.IBRX stock is currently trading near $8.04, while the 200-day moving average sits at approximately $2.95. The Golden Cross was established after the 50-day moving average rose above the 200-day moving average, and the widening gap between the two continues to reflect a strong upward trend.IBRX Price H ...